Market Overview:

The clinical nutrition market is the segment of the healthcare industry that deals with the provision of nutritional support to patients who are unable to meet their nutritional needs through regular food intake. This can be due to a variety of factors, such as illness, injury, surgery, or old age.

global clinical nutrition market size is expected to be worth around USD 85.2 billion by 2032 from USD 47.4 billion in 2022, growing at a CAGR of 6.20% during the forecast period from 2022 to 2032.

The enteral nutrition segment is expected to be the largest segment of the market, owing to the increasing number of patients requiring long-term nutritional support. The parenteral nutrition segment is expected to grow at the fastest CAGR during the forecast period, due to the increasing number of patients requiring short-term nutritional support.

– Please check this report :@

Market key Takeways:

  • The increasing prevalence of chronic diseases, such as obesity, diabetes, and cancer, is a major driver of the market growth.
  • The rising number of elderly people, who are more susceptible to malnutrition, is another driver of the market growth.
  • The increasing awareness of the importance of nutrition in maintaining good health is also a key driver of the market growth.
  • The development of new and innovative clinical nutrition products and services is also contributing to the market growth.
  • The enteral nutrition segment is expected to be the largest segment of the market, followed by the parenteral nutrition segment.

Market Key Players:

  • Braun Melsungen AG
  • Perrigo Company plc
  • Hero Nutritionals Inc.
  • Fresenius Kabi AG
  • Pfizer Inc.
  • Hospira Inc.
  • Abbott Laboratories Inc.
  • Reckitt Benckiser Group PLC
  • Other Key Players.

Regional Analysis:

-North America [United States, Canada, Mexico]
-South America [Brazil, Argentina, Columbia, Chile, Peru]
-Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
-Middle East & Africa [GCC, North Africa, South Africa]
-Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]mailto:[email protected]

Market Top Segmentations:

Based on the Route of Administration

  • Oral
  • Parental
  • Enteral

Based on Application

  • Metabolic Disorders
  • Malnutrition
  • Gastrointestinal Diseases
  • Cancer
  • Neurological Diseases
  • Other Diseases

Based on End-User

  • Adult
  • Pediatric
  • Geriatric

Make an inquiry before picking up this report @

Market Challenges:

  • Lack of standardization in nutritional interventions: There is no standard approach to providing clinical nutrition, which can make it difficult to ensure that patients are receiving the right amount and type of nutrients.
  • Concerns over the safety and efficacy of nutritional therapies: Some nutritional therapies have been linked to side effects, such as infections and allergic reactions. This can make patients and healthcare providers hesitant to use these therapies.
  • Limited availability of skilled healthcare professionals: There is a limited number of healthcare professionals trained in clinical nutrition. This can make it difficult to provide patients with the necessary care.
  • High cost of clinical nutrition: Clinical nutrition can be expensive, which can make it difficult for some patients to afford.
  • Regulatory challenges: Clinical nutrition products and services are subject to a variety of regulations, which can make it difficult to bring new products to market.


Global Business Development Team – (Powered by Prudour Pvt. Ltd.)

Send Email: [email protected]

Address: 420 Lexington Avenue, Suite 300 New York City, NY 10170, United States

Tel: +1 718 618 4351